Cargando…

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort

IMPORTANCE: Hepatocellular carcinoma (HCC) surveillance is underused in clinical practice, which may be owing to patient and clinician barriers. OBJECTIVE: To characterize HCC surveillance barriers and associations with clinical outcomes in a multicenter cohort of patients with cirrhosis. DESIGN, SE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parikh, Neehar D., Tayob, Nabihah, Al-Jarrah, Taim, Kramer, Jennifer, Melcher, Jennifer, Smith, Donna, Marquardt, Patrick, Liu, Po-Hong, Tang, Runlong, Kanwal, Fasiha, Singal, Amit G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308050/ https://www.ncbi.nlm.nih.gov/pubmed/35867057 http://dx.doi.org/10.1001/jamanetworkopen.2022.23504

Ejemplares similares

Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran’s Affairs Health Care System
por: Tayob, Nabihah, et al.
Publicado: (2018)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2016)

Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
por: Chen, Qiushi, et al.
Publicado: (2020)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
por: Marquardt, Patrick, et al.
Publicado: (2021)

Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice
por: Pandya, Prashant, et al.
Publicado: (2017)

Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality
por: Kanwal, Fasiha, et al.
Publicado: (2020)

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

Prognosis conversations in advanced liver disease: A qualitative interview study with health professionals and patients
por: Arney, Jennifer, et al.
Publicado: (2022)

Two mental models of integrated care for advanced liver disease: qualitative study of multidisciplinary health professionals
por: Arney, Jennifer, et al.
Publicado: (2022)

A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
por: Wang, Mengjun, et al.
Publicado: (2022)

A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022)

Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
por: Chhatwal, Jagpreet, et al.
Publicado: (2019)

An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
por: Wong, Robert J., et al.
Publicado: (2022)

Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality
por: Kim, Hyun-seok, et al.
Publicado: (2022)

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Parikh, Neehar D., et al.
Publicado: (2018)

Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies
por: Liang, Jing, et al.
Publicado: (2019)

Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection
por: Puenpatom, Amy, et al.
Publicado: (2020)

Is hepatocellular carcinoma surveillance in high-risk populations effective?
por: Onyirioha, Kristeen, et al.
Publicado: (2020)

Estimated Association Between Organ Availability and Presumed Consent in Solid Organ Transplant
por: DeRoos, Luke J., et al.
Publicado: (2019)

Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method
por: Lin, Yu, et al.
Publicado: (2022)

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response
por: Osho, Azeez, et al.
Publicado: (2020)

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
por: Brown, Andrew M., et al.
Publicado: (2022)

Body Composition Features Predict Overall Survival in Patients With Hepatocellular Carcinoma
por: Singal, Amit G, et al.
Publicado: (2016)

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
por: Hanouneh, Ibrahim A., et al.
Publicado: (2019)

Quality of Care in the Cirrhotic Patient
por: Volk, Michael L, et al.
Publicado: (2016)

PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
por: Gutierrez Reyes, Cristian D., et al.
Publicado: (2021)

The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
por: Harrison, Ariel C., et al.
Publicado: (2022)

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Kassab, Ihab, et al.
Publicado: (2023)

Examination of the Accuracy of Existing Overdose Surveillance Systems
por: Griffith, Jennifer, et al.
Publicado: (2023)

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
por: Singal, Amit G., et al.
Publicado: (2014)

2207. Barriers to HCV Treatment in a Safety-Net Hospital System
por: Gull, Sabhi, et al.
Publicado: (2018)

Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
por: Ioannou, George N., et al.
Publicado: (2020)

Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver
por: Lanham, Holly J., et al.
Publicado: (2022)

Defining Barriers and Facilitators to Advancement for Women in Academic Surgery
por: Thompson-Burdine, Julie A., et al.
Publicado: (2019)

The Impact of Biopsy Tool Choice and Rapid On-Site Evaluation on Diagnostic Accuracy for Malignant Lesions in the Prospective: Multicenter NAVIGATE Study
por: Gildea, Thomas R., et al.
Publicado: (2021)

Findings From Severe Maternal Morbidity Surveillance and Review in Maryland
por: Wolfson, Carrie, et al.
Publicado: (2022)

Spread of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South Africa
por: Moodley, Prashini, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_85lmh9d2f0pgj4c8idt5q98dqn